Sudarshan Chemical Industries Ltd
Sudarshan Chemical Industries Ltd Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
1 of 3 strong
Not discussed on this call: fundraise, order book.
The short version
The company projects reaching Rs.12,000 Crores+ in revenue post-Heubach acquisition, indicating aggressive growth potential (Page 14). Sudarshan expects a revenue CAGR of 5% to 7% over the next 2-3 years, with a focus on profitable growth rather than aggressive topline expansion.
From Sudarshan Chemical Industries Ltd's Q1 FY27 earnings-call transcript · updated 27 Aug 2026.
Revenue & Sales Performance
- The company projects reaching Rs.12,000 Crores+ in revenue post-Heubach acquisition, indicating aggressive growth potential (Page 14).
- Growth is expected from recapturing lost business due to past integration challenges within Heubach (Page 14).
- Revenue growth is anticipated to be in high single digits to low double digits for the acquired group, not a uniform 15% (Page 13).
- Legacy Sudarshan business is expected to continue growing at around 12%-13% (Page 5).
- Management expects a revenue CAGR of 5%-7% over the next 2-3 years, split between volume and value growth driven by premiumization (Page 8).
- The company is focused on profitable growth, avoiding hampering gross margins, emphasizing value capture and cost efficiencies (Page 9).
- Challenges like subdued demand in US/Europe coatings and plastics are seen as short-term; specialty segments show good growth potential (Page 10).
- Volume growth has been modest (~6% in Q1), with confidence rooted in business recovery and value capture initiatives (Page 6).
Profitability & Margins
See what Sudarshan Chemical Industries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- No substantial new capex is expected in the near term as current capacities are sufficient to support indicated growth.
- Moderate capex may be undertaken for special initiatives such as backward integration or new special projects.
- Any new investments will be driven by ROI considerations; only projects with good returns will be pursued.
- The company is implementing Project Integra (One SAP) in the current financial year to harmonize reporting systems, which is a strategic investment in IT infrastructure.
- Capital expenditure is thus focused on efficiency, integration, and select value-adding projects rather than large-scale capacity expansion.
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Sudarshan Chemical Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Sudarshan Chemical Industries Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹2.8K Cr, net profit ₹82 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Sudarshan Chemical Industries Ltd's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q2 FY26 earnings call →
- Q1 FY26 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
Others in Chemicals & Petrochemicals this season
- Solar Industries India Ltd (Q1 FY27)
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
- Indo Borax & Chemicals Ltd (Q1 FY27)
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
- SRF Ltd (Q1 FY27)
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…
- Deepak Fertilisers & Petrochemicals Corp Ltd (Q1 FY27)
Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions. Key concall takeaways from…
Frequently Asked Questions
What were Sudarshan Chemical Industries Ltd Q1 FY27 results?
The company projects reaching Rs.12,000 Crores+ in revenue post-Heubach acquisition, indicating aggressive growth potential (Page 14). Sudarshan expects a revenue CAGR of 5% to 7% over the next 2-3 years, with a focus on profitable growth rather than aggressive topline expansion.
What is Sudarshan Chemical Industries Ltd share price analysis?
Sudarshan Chemical Industries Ltd currently shows a below-average growth signal. The stock trades at a P/E of 95.2 with a market cap of ₹9,673 Cr. Investors should review the full earnings analysis for detailed insights.
Is Sudarshan Chemical Industries Ltd planning capital expenditure?
No substantial new capex is expected in the near term as current capacities are sufficient to support indicated growth.
Keep Sudarshan Chemical Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.